Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.

Hassan NJ, Simmonds SJ, Clarkson NG, Hanrahan S, Puklavec MJ, Bomb M, Barclay AN, Brown MH.

Mol Cell Biol. 2006 Sep;26(17):6727-38. Erratum in: Mol Cell Biol. 2009 Jun;29(12):3452.

2.

CD6 as a therapeutic target in autoimmune diseases: successes and challenges.

Pinto M, Carmo AM.

BioDrugs. 2013 Jun;27(3):191-202. doi: 10.1007/s40259-013-0027-4. Review.

PMID:
23568178
3.

CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses.

Brown MH.

Curr Drug Targets. 2016;17(6):619-29. Review.

PMID:
26302795
4.

[CD5 and CD6 molecules--similarities and differences].

Rupniewska ZM, Dmoszyńska M, Roliński J.

Pol Arch Med Wewn. 1999 Mar;101(3):245-50. Review. Polish. No abstract available.

PMID:
10697403
5.

Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses.

Santos RF, Oliveira L, Carmo AM.

Curr Drug Targets. 2016;17(6):630-9. Review.

PMID:
26028048
6.

Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.

Bowen MA, Aruffo AA, Bajorath J.

Proteins. 2000 Aug 15;40(3):420-8. Review.

PMID:
10861932
7.

Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis.

Dogra S, Uprety S, Suresh SH.

Expert Opin Biol Ther. 2017 Mar;17(3):395-402. doi: 10.1080/14712598.2017.1279601. Epub 2017 Jan 25. Review.

PMID:
28064543
8.

Clinical and experimental evidence for targeting CD6 in immune-based disorders.

Consuegra-Fernández M, Lin F, Fox DA, Lozano F.

Autoimmun Rev. 2018 May;17(5):493-503. doi: 10.1016/j.autrev.2017.12.004. Epub 2018 Mar 9. Review.

PMID:
29526637

Supplemental Content

Support Center